We report a mouse model of multiple osteochondromas (MO), an autosomal dominant disease in humans, also known as multiple hereditary exostoses (MHE or HME) and characterized by the formation of cartilage-capped osseous growths projecting from the metaphyses of endochondral bones. The pathogenesis of these osteochondromas has remained unclear. Mice heterozygous for Ext1 or Ext2, modeling the human genotypes that cause MO, occasionally develop solitary osteochondroma-like structures on ribs [Lin et al. (2000) (MHE or HME), is an autosomal dominant disorder characterized by shortened long bones and multiple cartilage-capped bony projections from the metaphyses of endochondral bones that develop during statural growth (1). In 0.5-3% of patients with MO, an osteochondroma eventually transforms into a chondrosarcoma (2). MO has been linked to loss-of-function mutations in the EXT1 (8q24.1) (3) and EXT2 (11p11-p12) (4) genes (5).
We report a mouse model of multiple osteochondromas (MO), an autosomal dominant disease in humans, also known as multiple hereditary exostoses (MHE or HME) and characterized by the formation of cartilage-capped osseous growths projecting from the metaphyses of endochondral bones. The pathogenesis of these osteochondromas has remained unclear. Mice heterozygous for Ext1 or Ext2, modeling the human genotypes that cause MO, occasionally develop solitary osteochondroma-like structures on ribs [Lin et Rather than model the germ-line genotype, we modeled the chimeric tissue genotype of somatic loss of heterozygosity (LOH), by conditionally inactivating Ext1 via headto-head loxP sites and temporally controlled Cre-recombinase in chondrocytes. These mice faithfully recapitulate the human phenotype of multiple metaphyseal osteochondromas. We also confirm homozygous disruption of Ext1 in osteochondroma chondrocytes and their origin in proliferating physeal chondrocytes. These results explain prior modeling failures with the necessity for somatic LOH in a developmentally regulated cell type.
osteochondroma | exostosis | loss of heterozygosity | growth plate | bone M ultiple osteochondromas (MO), alternatively called diaphyseal aclasis, osteochondromatosis, and multiple hereditary exostoses (MHE or HME), is an autosomal dominant disorder characterized by shortened long bones and multiple cartilage-capped bony projections from the metaphyses of endochondral bones that develop during statural growth (1) . In 0.5-3% of patients with MO, an osteochondroma eventually transforms into a chondrosarcoma (2) . MO has been linked to loss-of-function mutations in the EXT1 (8q24.1) (3) and EXT2 (11p11-p12) (4) genes (5) .
EXT1 and EXT2 encode ubiquitously expressed type II transmembrane glycosyltransferases (6) , which localize to the endoplasmic reticulum and Golgi complex (7) . The two genes act in hetero-oligomeric complexes performing the N-acetylglucosamine and D-glucuronic acid transferase activities required for the synthesis of heparan sulfate (HS) chains on proteoglycans (PGs) (8) . Besides their expected structural function, HSPGs have been shown to regulate ligand distribution and/or receptor binding of many signaling systems including the hedgehog, Wnt, and fibroblast growth factor families (9) .
Whereas many theories on the pathogenesis of osteochondromas in the setting of MO have been proposed, each hinges on two central questions. (i) Is the cellular origin of an osteochondroma a chondrocyte of the growth plate or a cell from the juxtaposed perichondrium/periosteum? (ii) Is an osteochondroma the result of haploinsufficiency-dependent misregulation of signals controlling growth plate maturation or of clonally occurring second mutations in the EXT genes (10) as has been shown for other genetically inherited tumor susceptibililty syndromes (11)?
Second mutations in or cytogenetic loss of the wild-type allele of EXT1 or EXT2 have been detected, but only in a subset of osteochondromas, leaving the pathogenetic role of loss of heterozygosity (LOH) unestablished (12) (13) (14) (15) (16) .
In mice, deletion of Ext1 or Ext2 results in a lack of HS biosynthesis; homozygous embryos die between E6.5 and E9.5 due to failure in mesoderm formation. Mice heterozygous for loss of Ext1 or Ext2 survive and are fertile. Small, solitary, osteochondromalike structures on ribs have been detected in 30% of heterozygous Ext2 +/− mice. However, unlike humans with MO, heterozygosity for neither Ext1 nor Ext2 disruption has led to shortened long bones or frequent development of larger osteochondromas on other endochondral bones (17, 18 ). Here we demonstrate that clonal, homozygous inactivation of Ext1 in chondrocytes at low prevalence results in frequent osteochondromas on the apendicular skeleton, mimicking the human MO phenotype.
Results
Strategy to Model Loss of Heterozygosity. Exon 2 of Ext1 codes for highly conserved amino acids of the catalytic center (100% amino acid homology between mouse and human). Missense mutations in exon 2, which lead to MO in humans, have been demonstrated to completely abrogate the enzymatic function of EXT1 in vitro (7, 19) . To investigate if low-prevalence clonal inactivation of Ext1 would result in osteochondroma formation in mice, we generated mice carrying an inducible loss-of-function allele of Ext1 (Ext1 e2neofl ), in which exon 2 was flanked by headto-head loxP sites (Fig. 1A) . Both heterozygous and homozygous carriers of the Ext1 e2neofl allele were healthy, displaying no obvious phenotype.
Although prolonged exposure of head-to-head loxP sites to Cre-recombinase has been demonstrated to cause chromosomal loss and apoptosis due to interchromatid translocations (20) (21) (22) (23) , limited exposure to Cre-recombinase yields a distribution of forward and inverted flanked fragments (24) . Homozygosity for a head-to-head flanked allele was therefore hypothezised to generate chimeric tissues containing a low prevalence of inversion of both alleles.
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This article is a PNAS Direct Submission. To determine if the previously described chromosomal loss and apoptosis from inverted loxP sites was applicable to our allele, we crossed homozygous Ext1 e2neofl/e2neofl mutants to mice carrying Cre-recombinase under the control of the collagen IIa1 promoter (Col2-Cre) (25) . No double-heterozygous Col2-cre; Ext1 e2neofl/+ offspring (0 of 113) were produced. Similarly, Ext1 e2neofl/e2neofl mutants crossed to mice expressing Crerecombinase from the Hprt locus produced only very small litters. No double-heterozygous Hprt-Cre;Ext1 e2neofl/+ mice were retrieved even at E11.5 (zero of four matings) ( Table 1) .
To test if chromosomal loss and apoptosis could be avoided by limited exposures to Cre-recombinase, we exposed E14.5 mouse embryonic fibroblasts (MEFs) isolated from heterozygous Ext1 e2neofl/+ and homozygous Ext1 e2neofl/e2neofl mutants to TATCre (26) . The cells remained healthy over at least five passages and had normal cytogenetic profiles on standard chromosomal spreads. Fluorescent in situ hybridization (FISH) with a chromosome 15 paint demonstrated the presence of the expected complement of two chromosomes 15 in homozygous Ext1 e2neofl/e2neofl cells after TATCre exposure (Fig. 1D) . Genotyping of the Ext1 allele detected all possible Cre-mediated recombination products predictable from the design of the targeting construct ( Fig. 1 B and C) .
Accordingly, introduction of a transgenic Cre-recombinase under the control of a doxycycline-inducible Col2 promoter (Col2-rtTA-Cre) (27) ) orientation (Fig. 1B) . Stable germ-line transmission of the generated alleles was confirmed by crossing founders (F 0 ) to C57B6 females. F 1 males that produced offspring (F 2 ) consistently carrying the allele in the expected orientation were used for further breeding. Both heterozygous Ext1 e2fl/+ and Ext1 e2flinv/+ mice were born at Mendelian ratios. To verify that exon 2 inversion generates a functionally null allele, we isolated embryos of Ext1 e2flinv/+ matings at E7.0. We detected 4 of 10 embryos that were small and had failed to undergo gastrulation (Fig. 2B ), similar to the phenotypes described for Ext1 −/− and Ext2 −/− mutants (17, 18) . PCR analysis of microdissected embryonic tissue confirmed that these were homozygous Ext1 e2flinv/e2flinv mutants. To further support the inactivity of the inverted allele we investigated the production of HS by immunohistochemistry using the 10E4 (Seikagaku) antibody. In contrast to wild-type and heterozygous embryos, which showed solid staining in both the embryonic and extraembryonic tissues and basal membranes, we detected HS only in the placenta, but not in the basal membranes of the Ext1 e2flinv/e2flinv embryos proper (Fig. 2 ).
Postnatal Inactivation of Ext1 Generates Osteochondromas. To investigate whether clonal inactivation of Ext1 function postnatally would lead to exostosis formation in mice, we induced expression of Cre-recombinase in chondrocytes from postnatal day 8 (P8) to P15 by administration of doxycycline in the drinking water.
Analysis of hematoxylin and eosin (H&E) and Safranin-O stained serial sections of knees and rib cages did not detect osteochondromas in 4-, 6-, or 10-week-old mutants, which lacked Cre-recombinase and/or homozygosity for the Ext1 e2fl or Ext1 e2neofl allele (Table 1 ). In contrast, Col2-rtTA-Cre;Ext1 e2neofl/e2neofl and Col2-rtTA-Cre;Ext1 e2fl/e2fl mice formed multiple osteochondromas with 100% penetrance after induction with doxycyline (Table 1 and Fig. 3 ). No differences could be detected in mutants with and without the neo cassette, excluding a nonspecific effect of the cassette itself on phenotype (29) . To more precisely specify the induction time, we switched to administration of doxycycline by i.p. injection to the lactating dam. One i.p. administration of doxycycline to the mother at P8 was sufficient to induce osteochondromas with 100% frequency. No difference in osteochondroma morphology was observed between the two administration strategies.
As in human patients, the induced osteochondromas developed on most endochondral bones and were mainly located near the major growth centers. Both described osteochondroma morphologies, pedunculated and sessile, were observed (Fig. 3F) . Planar reconstructions from microCT imaging revealed cortical and medullary continuity of each osteochondroma with the host bone, consistent with the radiographic diagnostic criteria in humans ( Fig. 3 B and C) .
To investigate the tissue composition of the osteochondromas, we analyzed sections through knees and rib cages at 4, 5, 6, and 8 weeks of age on a morphological and molecular level. In every mouse ≥6 weeks of age, safranin-O and H&E staining demonstrated cartilage-capped bone protuberances with cortical and medullary continuity and morphologic recapitulation of the physeal zones (Fig. 3) . The morphological observations were supported by in situ hybridization analysis (Fig. S1) , revealing a region of Col-II expression in cells at the peripheral cap of the osteochondroma and in columnar chondrocytes, which was followed by Ihh-expressing prehypertrophic chondrocytes and Col-X-expressing hypertrophic chondrocytes. As in osteochondromas arising in human MO patients, the osteochondromas induced in Col2-rtTA-Cre;Ext1 e2fl/e2fl mice mimic the organization of the growth plate on a molecular and morphological level.
Osteochondromas Originate in Proliferating Chondrocytes. The cellular origin of the osteochondroma has been disputed to be either a peripheral physeal chondrocyte or a cell in the adjacent perichondrium/periosteum. As the Col2 promoter has previously been shown to drive expression in both tissues embryonically (30), we analyzed Col2-rtTA-Cre;Rosa26
LacZ/+ mutants that had received doxycycline by drinking water at P8-P12. β-Galactosidase (β-gal) staining at P16 demonstrated expression of the allele in ≈50% of proliferating growth plate chondrocytes and rarely in cells of the periosteum and primary spongiosa (n = 5). Although showing infrequent Cre-mediated recombination, these periosteal cells could not be thus excluded as the origin for osteochondromas (Fig. 4A) .
We next introduced a tamoxifen-inducible Cre-recombinase under the control of the Osterix promoter (Osx-CreERT) (31) to Rosa26
LacZ/+ and Ext1 e2neofl/e2neofl mutants. β-Gal staining of P16 knees from Osx-CreERT;Rosa26
LacZ/+ mice that had received i.p. tamoxifen at P8 revealed expression in the osteoblasts of the perichondrium/periosteum and the primary spongiosa (n = 3). Expression was also detected in hypertrophic chondrocytes of the physis, but was excluded from the proliferative zone (Fig.  4B ). MicroCT analysis of the lower extremities of Osx-CreERT; Ext1 e2neofl/e2neofl mice induced with tamoxifen at P8 did not detect any signs of osteochondroma development at 9 weeks of age (n = 4) (Fig. 4E) . PCR on genomic DNA derived from bone tissues confirmed that recombination had taken place. Furthermore, safranin-O staining of serial sections of knees demonstrated mild aberrations in hypertrophic chondrocytes, but no osteochondromas (Fig. 4H) , strongly indicating that the likely origin of the osteochondroma is a proliferating growth plate chondrocyte, the only localized cell type expressing Col2-rtTA-Cre, but not Osx-CreERT.
To confirm the proliferating chondrocyte as the cell of origin, we investigated sections through knees of doxycycline-induced Col2-rtTA-Cre;Ext1 e2fl/e2fl mutants at 4 and 5 weeks of age. Small clusters of cells were noted, disrupting the columnar organization at the periphery of the growth plate. At slightly later stages, expanding peripheral clones of chondrocytes were found at the level of the primary spongiosa, often still in continuity with the proliferating zone of the physis. In situ hybridization with chondrocyte-specific markers revealed expression of Col-II and Ucma, but not Ihh and Col-X, confirming an early differentiation state in the chondrocytes of these early osteochondromas (Fig. S2) .
Homozygous Loss of Ext1 Is Required for Osteochondromagenesis. To confirm that osteochondromas are generated from homozygous mutant cells, we isolated clones of chondrocytes from sections of Col2-rtTA-Cre;Ext1 e2fl/e2fl exostoses at different stages of development by laser capture microdissection (LCM) (Fig. S3) . Genomic PCR using nested primer pairs to detect the Ext1 e2fl and the Ext1 e2flinv allele, respectively, revealed a mixture of all possible genotypes. About 70% of captured cell clusters produced neither the forward orientation nor the inverted PCR product, fitting the technical success rate from other studies using sections of paraformaldehyde-fixed, paraffin-embedded specimens for LCM (32, 33) . Morphologically distinct, small clones of cells frequently displayed a homozygous Ext1 e2fl/e2fl or Ext1 e2flinv/e2flinv genotype, indicating that the clustered appear- ance reflects a genetically clonal origin and that recombination is rare after doxycycline clearance. Of 55 clones successfully analyzed, 38 were homozygous for the inverted Ext1 e2flinv/e2flinv allele, 14 homozygous for the Ext1 e2fl/e2fl allele, and 3 heterozygous Ext1 e2fl/e2flinv (Fig. 5) . To understand the spatial distribution of genotypes within the osteochondromas, we tested parallel sections with LCM genotyping and 10E4 immunohistochemistry, confirming that HS-negative areas are consistently Ext1 e2flinv/e2flinv and that osteochondromas containing Ext1 e2fl/e2fl chondrocytes displayed small, discrete regions of HS synthesis (Fig. 5) . Screening of 10 osteochondromas with 10E4 immunohistochemistry demonstrated 6 with no detectable HS in the cap chondrocytes and 4 with a small minority of cells staining for HS, confirming that clonal dysfunction of Ext1 is present in the majority of chondrocytes in all osteochondromas, but that cells with functional Ext1 can be integrated into the mutant tissue during osteochondromagenesis.
Discussion
Phenotypic expression in mouse models of human genetic diseases that depend on somatic LOH is usually not detectable until late in the mouse life cycle (34, 35) . The stochastic likelihood of achieving such LOH in a developmentally limited, short-lived tissue, such as proliferating physeal chondrocytes, is very low. Furthermore, somatic LOH is not well modeled by high-density disruption of a gene in the tissue of interest, as would be typical of a traditional conditional knockout strategy.
To mimic the heritable form of human osteochondromagenesis, MO, we have generated mice in which head-to-head loxP sites flank the second exon of Ext1. We demonstrate that limited duration of Cre-mediated recombination in chondrocytes leads to clonal inactivation of the Ext1 gene with low prevalence. In contrast to ubiquitous deletion of one or both copies of Ext1, such clonal deletions generate exostoses with high penetrance, strongly indicating that LOH is the inductive event for osteochondromas in humans. Although conflicting data have been published on the genetic status of human osteochondroma chondrocytes (2), somatic loss of the wild-type EXT1 or EXT2 allele has been identified in many hereditary and even some sporadic osteochondromas (36) and may have been masked in others by the occasional integration of wild-type chondrocytes into the osteochondroma cap, as seen in a minority of murineinduced osteochondromas. There is corroborating evidence for LOH as a mechanism from Ext2 null zebrafish that have disorganized rather than ordered columnar chondrocyte proliferation (37) . In the mice, immunohistochemistry against HS proved a reliable surrogate for LCM genotyping and strongly supported the absence of Ext1 function in the majority of mice show early, middle, and fully developed osteochondromas, respectively, and both pedunculated (F, black arrow), and sessile (F, white arrow) morphologies. LacZ/+ after P8-12 doxycyline by drinking water shows abundant staining of proliferating chondrocytes (C) with minimal staining of the inner layer of cells in the perichondrium/periosteum (P). (B) Osx-CreERT;Rosa26
LacZ/+ mice after P8 injection of tamoxifen have more robust staining of the inner layer of perichondrium/periosteum (P), with additional staining of hypertrophic chondrocytes (H), but not proliferating chondrocytes. (C) Rosa26
LacZ/+ mice without Crerecombinase demonstrate only mild background staining of primary spongiosal osteoblasts. Three-dimensional knee renderings of microCTs from 9-week-old Col2-rtTA-Cre;Ext1 chondrocytes in all osteochondromas. Interestingly, reduced HS levels have been found in most human osteochondromas independent of genetically identified LOH (38, 39) . Investigation of the osteochondroma cellular origin has also been challenging in humans, as only late-stage osteochondromas are routinely surgically retrieved for study. These demonstrate continuity with the cortical and medullary bone, suggesting an at least temporary defect in the bone collar during osteochondromagenesis. Direct injury to the perichondrial ossification groove has induced solitary osteochondroma-like structures in prior animal models (40) . However, although EXT1-or EXT2-null chondrocytes have been identified in the cartilaginous caps of osteochondromas, the perichondrium over the same has shown normal EXT gene expression when investigated (36) . Further, a temporary defect in the bone collar might alternatively be generated by altered signaling to the perichondrium, rather than a cell-intrinsic defect there. Peripheral displacement of the early osteochondroma chondrocytes from the growth plate may push the overlying perichondrium away from the osteogenic signals from the physis or provide alternate, nonosteogenic, paracrine signals (Fig. 6) . Although the disparate results of deleting Ext1 function in Osx-versus Col2-expressing cells in no way exclude a contribution of the perichondrial cells to osteochondromagenesis, they strongly indicate that the original molecular event, the clonal inactivation of HS synthesis, takes place in a growth plate chondrocyte.
Although our data settle important controversies, many questions remain unanswered. What happens to a central clone of chondrocytes lacking Ext1 function? Although we did observe rare epiphyseal enchondromas, we did not detect them in the metaphysis. Also, what signals are altered by the clonal Ext1 dysfunction that gives rise to osteochondromas? Although only Ihh has been demonstrated to be affected by Ext1 dysfunction specifically in chondrocytes (41) , the diffusion gradients and ligand-receptor interactions of other pathways important to physeal development have been shown to be sensitive to HS levels in other tissues (9) . We did not find obviously aberrant expression of Ihh or Ptch1 in early osteochondromas. Further investigation of Ihh and other signaling systems will be required to elucidate the contribution of individual signal disturbances from HS absence.
Materials and Methods
Transgenic Mice. A total of 3.6 kb of genomic DNA including exon 2 of Ext1 ; Fig. 1A ). The linearized targeting vector was electroporated into R1 ES cells (129 × 1/SvJ3 129S1/Sv). G418-resistant clones were screened by long-range PCR to identify Ext1-targeted ES cell lines. Ends of PCR products were sequenced to confirm identity. One positive cell line was injected into blastocysts. Germline transmission and further genotyping were initially confirmed by long-range PCR from tail-tip-derived DNA. Routine genotyping was done with primers A and B of a panel of primers used to detect recombination ( Fig. 1 B and C ) . Rosa26 LacZ (43), Col2-rtTA-Cre (27), Hprt-Cre (44), Col2-Cre (25), and OsxCreERT (31) mice were genotyped as described. In addition, presence or absence of Cre-recombinase was confirmed by PCR in each mouse. Expression of Cre-recombinase in Col2-rtTA-Cre mice was induced either by administration of 4 mg/mL doxycycline in 5% sucrose through the drinking water of the lactating mother at P8 for 8 days or by i.p. injection of doxycycline (80 μg/g body mass) in PBS into lactating mothers at P8. Nuclear translocation of CreERT was induced in Osx-CreERT mice by i.p. administration of tamoxifen (0.2 mg/g body mass) in corn oil directly to the mutants.
Cell Culture. E14.5 embryos from Ext1 e2neofl/+ matings were harvested, disemboweled, dissociated in trypsin, and plated in Dulbecco's modified Eagle medium (DMEM) with 10% FBS. Nonadherent cells were discarded. Washed cells were treated with TATCre (4 mM in DMEM) for 3 h before adding serum-containing media. For cytogenetics, cultures were arrested with methotrexate, released with thymidine, treated with colcemid (Invitrogen), swelled in hypo-osmolar potassium chloride, fixed, and stained with Sytox Green (MBL International) or DAPI (Vectashield). Single whole mouse chromosome paint probe 15 (Applied Spectral Imaging) was applied following the manufacturer's recommended protocol. The fully developed osteochondroma, once completely independent from direct physeal signaling, begins to organize itself loosely into the proliferative (P) and hypertrophic (H) zones of a growth plate, as well as form its own primary spongiosa and bone collar, each in continuity with the host bone.
μCT. Mice were killed at 9 or 10 weeks of age. No contrast was used. A General Electric Medical Systems EVS-RS9 μCT scanned the lower half of the body. Planar reconstructions and three-dimensional rendering were achieved with Microview software (General Electric).
Tissue Analysis. Knees and rib cages were harvested, fixed in 10% formalin in PBS, and decalcified in 5% formic acid for histology or fixed in 4% paraformaldehyde in PBS and decalcified in 25% EDTA (pH 7.4) at 37°C for histology, in situ hybridization, immunohistochemistry, β-gal staining, and LCM. Five-to 10-μm sections from paraffin-embedded tissue were stained with H&E or safranin-O. Six-micrometer sections were processed for radioactive in situ hybridization using [P33]-UTP-labeled antisense riboprobes as described (45) . Probes for in situ hybridization were as follows: Col2 (46), ColX (47), Ihh (48), Ptch1 (49), and Ucma (50). β-Gal staining was performed on frozen sections as previously described (51) and counterstained with nuclear fast red.
For immunohistochemistry, 6-μm paraffin sections were pretreated with 10,000 units/mL hyaluronidase I (Sigma) for 30 min at 37°C, quenched with 3% H 2 O 2 in PBS for 30 min, blocked in 10% goat serum in PBS for 30 min, and incubated overnight at 4°C with anti-10E4 antibody (Seikagaku), diluted 1:100 in blocking solution.
Goat biotinylated secondary antibody against mouse IgM (Vector Laboratories) at a dilution of 1:100 was applied for 30 min. Detection was performed with Streptavidin-HRP (Perkin-Elmer) diluted 1:100 in PBS for 30 min followed by incubation with DAB for 5 min and then counterstaining with Methyl Green (Sigma).
LCM. Six-micrometer paraffin sections were transferred to PALM MembraneSlides, dried, deparaffinized, and stained with Mayer's hematoxylin and eosin. Clones of 1-20 cells were then captured with the PALM Microbeam System (Carl Zeiss MicroImaging) and digested in Proteinase K. PCR was performed directly on the heatinactivated cell lysate with outer primers. Outer primer PCR products were then used as templates for subsequent nested PCRs using inner primers.
